MK-0000-082

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK-0000-082, covering 2015-01-30 to 2015-01-30. Get the full timeline:

Most recent: Clinical Trial Update: Biomarkers of Muscle Anabolism (MK-0000-082) [Phase 1]